<SEC-DOCUMENT>0001193125-23-163060.txt : 20230608
<SEC-HEADER>0001193125-23-163060.hdr.sgml : 20230608
<ACCEPTANCE-DATETIME>20230608083058
ACCESSION NUMBER:		0001193125-23-163060
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230608
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230608
DATE AS OF CHANGE:		20230608

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEVA PHARMACEUTICAL INDUSTRIES LTD
		CENTRAL INDEX KEY:			0000818686
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16174
		FILM NUMBER:		231000774

	BUSINESS ADDRESS:	
		STREET 1:		5 BAZEL ST
		STREET 2:		P O B 3190
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49131
		BUSINESS PHONE:		9729267267

	MAIL ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		5 BAZEL ST PO B 3190
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49131
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d461805d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:teva="http://www.tevapharm.com/20230608" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-06-08_to_2023-06-08">TEVA PHARMACEUTICAL INDUSTRIES LTD</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-06-08_to_2023-06-08">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-06-08_to_2023-06-08">0000818686</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="teva-20230608.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-06-08_to_2023-06-08"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000818686</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-08</xbrli:startDate> <xbrli:endDate>2023-06-08</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-06-08_to_2023-06-08">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported) <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-06-08_to_2023-06-08" format="ixt:datemonthdayyearen">June&#160;8, 2023</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-06-08_to_2023-06-08" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-06-08_to_2023-06-08">001-16174</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-06-08_to_2023-06-08">00-0000000</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:100%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-06-08_to_2023-06-08">124 Dvora Hanevi&#8217;a Street</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-06-08_to_2023-06-08">Tel Aviv</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-06-08_to_2023-06-08">6944020</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2023-06-08_to_2023-06-08" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices, including Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">+<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-06-08_to_2023-06-08">972</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-06-08_to_2023-06-08">3-914-8213</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, including Area Code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-06-08_to_2023-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-06-08_to_2023-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-06-08_to_2023-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-06-08_to_2023-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-06-08_to_2023-06-08">American Depositary Shares, each representing one Ordinary Share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-06-08_to_2023-06-08">TEVA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-06-08_to_2023-06-08" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging Growth Company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-06-08_to_2023-06-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">ITEM&#160;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;8, 2023, Teva Pharmaceutical Industries Ltd. (the &#8220;Company&#8221;) determined that it will make effective its nationwide agreement to settle a substantial majority of the opioids-related claims brought against the Company by various states and subdivisions (the &#8220;Nationwide Opioids Settlement Agreement&#8221;), having previously secured sufficient participation by those states and subdivisions. The Nationwide Opioids Settlement Agreement will become effective on August&#160;7, 2023. Under the terms of the Nationwide Opioids Settlement Agreement, the Company will pay the participating states and subdivisions up to $4.25&#160;billion (including already settled cases, excluding the settlement with the state of Nevada, which is discussed below), spread over 13 years. This total includes the supply of up to $1.2&#160;billion of the Company&#8217;s generic version of Narcan<sup style="font-size:75%; vertical-align:top">&#174;</sup> (naloxone hydrochloride nasal spray), valued at wholesale acquisition cost, over 10 years or cash at 20% of the wholesale acquisition cost ($240 million) in lieu of product. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">ITEM&#160;7.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, on June&#160;7, 2023 the Company reached a settlement to resolve all opioid-related claims brought by the state of Nevada and its litigating subdivisions and special districts. Trial in the state&#8217;s case had been scheduled to begin in August 2023. Under the terms of the settlement with Nevada, Teva will pay Nevada $193&#160;million over 20 years (including all fees and costs). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company issued a press release on June&#160;8, 2023 to announce that it has fully resolved its Nationwide Opioids Settlement Agreement and to announce its separate settlement with the state of Nevada. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. As of the date of this Current Report on Form <span style="white-space:nowrap">8-K,</span> the Company has settled opioid claims brought by all 50 U.S. states and more than 99% of the litigating subdivisions and special districts within those states. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 and Exhibit 99.1 hereto is being furnished to the Securities and Exchange Commission (the &#8220;Commission&#8221;) and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) nor shall it be deemed incorporated by reference in any filing made by the Company under the&#160;Securities Act&#160;or the Exchange Act, except as set forth by specific reference in such filing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cautionary Statements Regarding Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Nationwide Opioids Settlement Agreement and the expected resolution of the opioids-related claims brought against the Company by various state and political subdivisions contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management&#8217;s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;target,&#8221; &#8220;may,&#8221; &#8220;project,&#8221; &#8220;guidance,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe&#8221; and other words and terms of similar meaning and expression. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the Company undertakes no obligation to publicly update forward-looking statements. Risk factors include, but are not limited to: the Nationwide Opioids Settlement Agreement is not expected to result in a resolution of all governmental entity claims against the Company regarding its role in distributing opioids; the Company expects to continue to experience costly and disruptive legal disputes and settlements related to distribution of controlled substances, including opioids; and the settlement payments that the Company is required to make under the Nationwide Opioids Settlement Agreement may have an adverse impact on the Company&#8217;s operations and cash flows and there is no assurance that the Company will have the liquidity or other resources necessary to make such payments and provide supplies of its generic version of Narcan<sup style="font-size:75%; vertical-align:top">&#174;</sup>&#160;(naloxone hydrochloride nasal spray) in the amounts and at the times required under the terms of the Nationwide Opioids Settlement Agreement. Investors should read the important risk factors described in the Company&#8217;s most recent Annual Report on Form <span style="white-space:nowrap">10-K,</span> Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> and Current Reports on Form <span style="white-space:nowrap">8-K</span> filed with the Commission. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">ITEM&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit</span><br /><span style="font-weight:bold">No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description of Document</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d461805dex991.htm">Press release of the Company issued on June&#160;8, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:47%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:46%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="5"><span style="font-weight:bold">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="4"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: June&#160;8, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;&#160;&#160;&#160;By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eli Kalif</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;&#160;&#160;Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3">Eli Kalif</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;&#160;&#160;Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3">Executive Vice President, Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d461805dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g461805dsp01.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g461805dsp01a.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:-130pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TEVA CONCLUDES NATIONWIDE OPIOIDS SETTLEMENT AGREEMENT </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Settles with all 50 states and 99</I><I></I><I>&nbsp;percent of litigating subdivisions </I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Shipments of life-saving generic
Narcan</I><I><SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP></I><I> (naloxone hydrochloride nasal spray) have already begun; payments to states to begin in the second half of 2023</I> </P></TD>
<TD WIDTH="13%">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Separate settlement reached with the final state of Nevada</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TEL AVIV, Israel&nbsp;&amp; PARSIPPANY, N.J.<B>,</B><B></B>&nbsp;June&nbsp;8, 2023&nbsp;&#151;&nbsp;Teva Pharmaceuticals, a U.S. affiliate of Teva
Pharmaceutical Industries Ltd. (NYSE and TASE:&nbsp;TEVA),&nbsp;today announced that the Company has fully resolved its nationwide settlement agreement related to opioid claims brought by U.S. states, their subdivisions, and special districts, and
has reached a separate settlement with the final state of Nevada. Teva will pay Nevada $193&nbsp;million over 20 years (including all fees and costs), and this settlement resolves the case prior to trial, which had been scheduled to begin in August
2023.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With these developments, Teva has resolved its opioid litigation with all 50 U.S. states and more than 99% of the litigating subdivisions and
special districts. The Company anticipates making its first payment under the nationwide opioids settlement agreement in the second half of 2023. Teva has already begun shipments of its generic version of the life-saving medication, Narcan<I><SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP></I> (naloxone hydrochloride nasal spray) under its prior opioid settlements, and it expects to expand these shipments under the nationwide opioids settlement agreement in 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While the final agreement includes no admission of wrongdoing, it remains in the Company&#146;s best interest &#150; and in the interest of those impacted by
the opioid crisis &#150; to conclude this settlement and for Teva to continue to focus on the patients it serves every day. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Teva Pharmaceuticals
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people&#146;s lives for more than a
century. We are a global leader in generic and innovative medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200&nbsp;million people around the world take a Teva medicine every day and are served by
one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative medicines research and operations supporting our growing portfolio of innovative
medicines and biopharmaceutical products. Learn more at <U>www.tevapharm.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Note Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains &#147;forward-looking statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995, which are based
on management&#146;s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or
implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as &#147;should,&#148; &#147;expect,&#148; &#147;anticipate,&#148; &#147;estimate,&#148; &#147;target,&#148; &#147;may,&#148;
&#147;project,&#148; &#147;guidance,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;believe&#148; and other words and terms of similar meaning and expression. The reader should not place undue reliance on forward-looking statements, which speak
only as of the date they are first made. Except to the extent required by law, the Company undertakes no obligation to publicly update forward-looking statements. Risk factors include, but are not limited to: the nationwide opioids settlement
agreement is not expected to result in a resolution of all governmental entity claims against the Company regarding its role in distributing opioids; the Company expects to continue to experience costly and disruptive legal disputes and settlements
related to distribution of controlled substances, including opioids; and the settlement payments that the Company is required to make under the nationwide opioids settlement agreement may have an adverse impact on the Company&#146;s operations and
cash flows and there is no assurance that the Company will have the liquidity or other resources necessary to make such payments and provide supplies of its generic version of Narcan<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>
(naloxone hydrochloride nasal spray) in the amounts and at the times required under the terms of the nationwide opioids settlement agreement. Investors should read the important risk factors described in the Company&#146;s most recent Annual Report
on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the Commission. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>teva-20230608.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 6/8/2023 3:21:43 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:teva="http://www.tevapharm.com/20230608"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.tevapharm.com/20230608"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20230608_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="teva-20230608_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>teva-20230608_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 6/8/2023 3:21:44 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>teva-20230608_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 6/8/2023 3:21:44 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="teva-20230608.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g461805dsp01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g461805dsp01.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( #8 =P,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /W[)V@]MH)],8I-\J;_ )5?[@_ ^/\ 6?VZOV;= U;5M#U'
MQEJD6H:+J5]I5_''X1\4S1I>:;=2V=W''-'I)25%G@D ="58 $$@U[5+A_-*
MT*=6G13IUH\T6W;1GBO/LNIRJ0=5\U)\K7GLOQ/JW1M6L->TG3-;TN?[3IFL
M6%EJFG7&R2+[18W]M%=VD_E2JKQ^9;S1MM=58;L, 00/(G%TYSI27+.D^62\
MUHSV8R4X4Y1VDE)>AJ5(PH * "@ H * "@ H * "@ H * /$/BE^T5\'/@QJ
M6FZ-\2?&*^'-2UBQ?4M/M%T+Q+K$DUBD\EJ9V;0-&O5ME,\4J*)FC+&)RH(0
MD=>%R['8VG*>%H^TIPER2=TK;=VNC.#%9E@\%4A2Q%7DJ27-&/>W_#'\V/CS
M4['6O''C36-+F^T:;JOBOQ'J>GSB.6'[197^L7EW:3>3.B21%X)8VV2HCKNP
MRJP('Z[@HU:&&P5.7O3H4HQ4?[R5DOO/RO%NG5Q&*E!<L9U')-:65[Z?(_<K
MX<?ML_LR>'_AYX%T+5/B2;35-$\&^&-*U*U'@WQ_.+6_T[1+"TNX/.MO"LD4
MH2>%UWQ.Z,%!5BI!/YOBL@S:>)Q52&$E[U2<[WCM=M?:O:VY^AX7.\OI8?#0
ME6UA3C&SONE8^R_"'C#P]X\\,:1XP\*:B-4\.:[:?;M+U$6UY9BZM=[Q^9]E
MO[>"YMV$D;J8YH8W4J05!%>!6ISPTY4JZ<:D-TM_P/<HUH5Z2JTW>,EH>,_$
M[]J_X$_":^ET;Q7XXMF\009$OA_0K6\U_5;=T +17R:9#+!I<X!!$5]/;.5(
M95*\UZ."R;,L;&,\/0<:>GO3]U/YO\TK'!B\WP."TJUESK>,=7]WZ''>"/VY
M?V=/&VIQ:/!XRF\.:A<.B6J>+]-N-"M+AW8(J+JDADL+=MQ7BYNH<[OESAMN
M^(X?S7#1<Y4(RA'XG"7,TN]MW\DV94,]RVLXQC6E%O92C9?>?7$<R2QB6-@\
M;#<K(00RD9!4CJ",$8KQI6@VI7BX7NFNVYZZE%Q4HOFB]C"\/^*M%\2K=G2;
MHSFPNI+.ZB>-X989HF*_-%( WEM@E) "K '!R"!X63<0Y7GBK_V?7YY86I*%
M2+TE%QDXO3M=&<*T*C<8/X=&=&>!]/Z5[NWR-5^1D:UK>G>']/N-3U2Y%K9V
MBJTDA!8DLP1(XT4%I)&=E554$DGV./.S3-,%D^"K8_'UXT,+1C=N_O:=(KJ_
M)&=2K"A%RF[);$^FZE;:KIUEJ=FSM:7]K!>6[.C1N8;B)98RT;8*-L894\@\
M5M@L71QN$H8S#3YL/B81G3EUY9;:%Q?-%2CM+8\ ^)?[6/P(^$]_-HWBKQS:
MR:_;';<:!X?M;SQ!JEI(H):&_32X98-,N ,'R;V>W<@@A2""?<P>3YGBX\U+
M#OEZ2E[L?Q_"VGF>9BLWP&$ERU*^JW4=;?)')>$?VYOV;O%^HQ:5#XYD\/WL
M[JEO_P )7H^HZ)8RDXP6U:6%["T7/&;JZ@R>F<''16R#-:%-U)892C'=0DG+
MLM-WK;:[.>CGN75ZD:5/$.,Y;.<6HZ*[N^FB=O,WO%/[9'[.'@O7]3\+^(OB
M3'9ZUHUPMKJ%M;^%_&NJPPSM''*$34-)\.7-G=#RY4.Z">1021G*D#.ED6;U
MJ=*K3P<N63ZN*]-&TU\TC:IG>6T:DJ53%13C;X;[WMNCZ%\.Z_I/BG0M&\3:
M!>+?Z'K^F66L:1?)'-$EYINHVT=W972Q7$<<L2RV\L;[)41UW8958$#S*D)T
M:DJ56/)4IR<&O-7O]UF>E2G&I&-2E)RA)73\NA\-_M;_ +('BC]HCQAX8\3^
M'_%N@^'X]#\-MH-S9ZQ::C))+(NJ7>HQW-O/8HXVE;QT*LJ%3$,,1(0OT629
MY1RK#5J%2A.3J5%-.-K+1+5-KM<\#.<CJYEB:->G5C&-*FX-.]]V]//70_"[
MQ%HTWAK7]>\/7$L4]QH.L:IHLT\(=89I=*O9[&26)9!N$;O 6 8 @,,\]?T:
MC66(H4*D4U[2"FDM[;].I^?5:3H5:U-O^'+D;>U]C]!/"_\ P3=^(?B?PUX=
M\3VGQ"\&VEMXAT/2==MK>>TUPSVT&K6%OJ$,,IBMBHFCCN$1BA(+*6'6OF:G
M%^&H5JE+ZM.]";C)W7V79[R78^GI<+UJU*C/V\8J:4NNBWZ(]R_:%^)'BG]D
MG]G[X7_ KPSK\#>/M4T34++4?$VEK- =+T"UGF-]>:2+AC+:7]W>:BEK;739
M>..QNY$\NX$+Q>;E>%HY[FV,S"K3E'"T7"48-+E<E:RENK.WO+SWMOW9EB:^
M3Y=A<#3J15:49\TU\7*D]O-='Y'PQ^S;^R[XM_:2UC5[J+5T\.>%M%FB77O%
M=];RZG/-J-V3.FGZ=9_:(6U+4VC<SS/+<1)"DJ/([/-''+]%F^;8?*:-/#TX
M.K5^*$5I&-MKV6RM_6MOGLKRG$9M5G5JU%2BOMOX_E?2_8]-_:;_ &'=4^!/
MA-/'OASQ5/XS\,6MW:V7B!+K2DTO4=#%]*EI97[^1>SPWNGRWTT5LS*L$D4E
MS;C;(KL\/+D_$<<QK?5:^&A0F](-.7O/M9KY_>=F:\/RR^A]8H8F=:,-9W45
MRI6UT9[9_P $]?VC/$%UKB_ CQ=JDNHZ7-I5W=_#^XNV9[S3;C3(I;V_\."X
M=BTVF-IJ7-U;QL#]F^P21(?+EC2#R^*<GA3P_P!>P]-1E*\*L(Z+712\FN_8
M[^&\WG4J3P%>3FHQYJ3EU27P^AZQI7Q<F\+'6/'7AB1;N*SO;^+4M,F;8EPE
MKJ;1WNG76S_4W"G/ER@-LS'( R/B3^+,@HYWPIXD4\LJ\U"GFF.G&46KTZV%
MJ<TXR3VYHO9G-C<]_LO X[,Z,55>$;<X/:RDE)?<V??/A/QSH'B_P=I_C;2K
MY?["O]/;4#<7)CB^PQP!Q>PWYWE8)K26&:.8%B%:%OFVX-?T\TK/HK=-_P"D
M?4X#.,'F.6TLUPU1+"SI^T<ND$E><9=FM3X>\5_'"'XEKKNI0RK8>"_#NL7U
MOICSDQ&YM++3K6237-05AF-Y6FN3%&0#'"R*5$CL3_/'BW4S7%YWE&08)2K4
M:\$X4(7M*I)I<TDNR=[;(^0PG$]+B"./KTOW6!P59TJ;6DIVWG+RNC&_:<_:
M:U#X8_ /X8:9X#NGL/%GQ0\)6,UEJ#J#>>'_  NFC637VI0H&_T?5IY+ZUMK
M9VSY?^ERQGS;5#7])>'O#'L<#E^&QKO#*Z%.%2*VE6M>,7_=C;5:?=H>WF&;
M.AE6&5)\M7$PT:WC%?:1^5/P>^"'Q%^//B2XT'P3IZ74EN([K7->U6XDM-%T
MB.XDD"76JZAY4SF:5UF*0PQ7-Q+LF9(G6*4I^J8[,<%EM+GKJ44E:G3II<SZ
M:)Z;;WV1\C@\OQF93E[)*-W[TYM\NFNK6NMK*W5GT[XZ_P""=7QJ\(^'[C7M
M%U3PMXWDL('NKS1-!EU.VUEXXD+R/IEMJ-A%#J4BJK'REGCGD.!%%+(X4>-A
M.*\NQ%3V56E6HJ3LI3C%0_[>:U5^^R>]EJ>EB.&<?0@JD9T9\B3Y82ES/T3T
M=MWY(^ W1T=DE5TDC;RW21621&C^0QLC %"NW;M(&,8QQ7U5)07LI4W>#UCY
M:'S\XM.I&I'EG'?Y;?<U<_I[_9P_Y-_^"GM\+? G_J-:=7XUF:7]I8[3X:]1
MKUNU^K/U?+'_ ,)^#\Z4;_<>U8'I7&=UK>5C^5+XH_\ )2_B+[>.O%W_ *?[
M^OVC+THX/*^5<K]C#;3HNQ^/X[7%8Q/5.N[I_P"(_IF^$ Q\)OAB.F/AWX*]
ML8\-:7Z5^/XW_?<=YUZG_I3/UC")+#86RMRTHV^Y'XP?\%)+NYF^/^EP3%Q!
M9_#?P]%:*6W*(GUCQ)<2.% ^0FXN) <\G:#G;@#[_A%\N6XGI?$2NNZ5--)]
MTK;'P_%"OF&'5O\ F'C9>;G9_-K1OKU/C/P_+\1+>Q8>%)/&L&F27+N__"/-
MKL=@]XJ1QO(W]FXB:X\M(5+'+85!G %?1UJ66NHEBHT?;N%XNHH7VNE>2VOY
MI>AX%*6/]FY4/:^SC+E:@Y)=FO=:U]$:EZOQ>U&VELM03XD7]G.H6>TO5\47
M5M,JLKJLL$X9)%#JK893RH/45A"C@*,E.#PE*4=I1]E&2])1DFOD4UCYQ=/V
M.*DI:.+J5G%^33T:\F>N_LI^%_&=A^T5\)KI?#7B2UC@\4Q&ZN'T74HHK>P>
MSN8=0EGE>U"PVWV&6X#NS*H4')QP>3.:N%EE>-7UFG-^S;4?:)MNZMISN[^3
M.S)\-BJ>98-O"5*48RLY>\DERO\ #R.W\5:S?_#OQ]\5/"=XS1:5<^)?$6EW
MD5YNC">7K$ZZ=J:CYPCF)8CN&4>*89.%C=/QO->&\%G&-R3,^1O,,JK*<)0M
MSN*32A)Z2=/7X;M:;'RN>_6:%+/,NCS-8F%11B[[WOHKVOIY'O7@/XD:AHW[
M._Q=\*PWGE>9K7ABVT_=*PD2U\5->PZ_;P*8R/)DLM!=&0, #>SN1N;#]DU.
MFY*:<.1JZV]=O(^9RK/\3@N!N(,OA+V53VU"%**<HRC3JJU3E26FL?+=GRWJ
MGC&[/A^3P?8S*MG_ &Q+>:J\+MYDTXM=.6WLI!CB*%(5F*AFWO)'G!B /''A
M?!_V[1XDK4W+$TZ/LL-[11:C'K5AS7:J+9324E?<Z^&9XC!Y.L+RN$L7-2>Z
M;4GY;J_=FW^VQ97^B>+O@]X8O4F@_P"$<_9\^'.FK;S JT5S%-KL=\SQJQ5)
MFNHY8W(R,VZKD[!7ZKPK&,<!BJBBG.5:[=M6TK:L_1\W52E++</)-*&&BK/H
MU:^FU^Y^C'_!.#2M+LO@!+J%I#"-0UCQMX@FU:=54SR264.GV-G%+)RWEQVD
M4;)&3A3.[ 9E8M\QQ75J3S6-.2]R%*/*M;+1-M)Z*[;3:L?6<+QBLMD[*[JR
M3=NBV7RML??DBJ$;Y0<8) '4 C/0>F:^=^%-[.*=ODG8^CM>RV_K^D?S8?M@
M:/I6@_M)_%C3]%BA@L6U^TU$Q0!5B6_UK1-*UG5MJIPA.K7]ZQ4?=8D=17ZY
MPY6J5LJP+J+6,+)VU=I-*_>RT^1^6YU2A3S3'*/NJ*345MK;IL?O7^S?_P F
M_?!3_LEG@3_U&M.K\PS+_D98_P#Z_P _S/T3+/\ D78/_KU#\CV@G:#_ +()
MQ]!7!*ZC*VC2=ON.[;Y'\O?[0?AF]\'?'#XJZ!J$+P20>.O$5Y:I("K2Z7JV
MHS:OH]R ^"5GTJ^LI@>1^^P"<9/['E%6-;+<!7C44H4H1IN*M[LEINNQ^29I
M"6&Q]>$Z;M.IS):][GZE?!#]OWX/Z1\*/"VA?$";7="\4^$O#NG>'[FUL]%N
M]5MM:&B6$5A:WVG75F&CBDN8+:%WBNVM5CED=%9HU60_$YGPSF+QE6KA*:G1
MKS<KW^'F=[OK[M]-]%KKO]E@N(\!3PM*&(J.-2G%1M;HM+:>FYX#^VN=!^.G
M@GP!^TU\-?M>H^';2"Z\ >,$N;=+?4_#TUMJ4U[H8UJRMY9UM,W&I:E$9#*T
M?_$RTPQNRWD6[U>&G4R[$8C)L<_95JS5:C)I)2E:SCV:DDH^6NS.#//9XW#4
M,WP:YXT+4JBZPC>ZG;;W/BU6MK.ZT.2_8L_:TT7X')JW@3X@)>KX&US5?[;L
M]:L+>2^G\.:O+!!:7[7=C$KW%UI5U;VEH66UCDEBEMRR0R"X<Q]/$60U<SE'
M&82?-B*2494KVNE\TK;[]SDR7.H9=S87&)*C4?-"IRQT?2Z2/T4\9_MW_LZ^
M%]!EU32O&#>--1:-O[/T#PYIFH_;KF8H6C%U<:C9VUMID&XH'DN) ZC=LAF=
M"E?)4.&LWJ5?9U,-[&%]9.<&H+J[+5V['TE?B'*Z5'GIU?:32T@HI<SZ+96^
M1K_LM?M2Z+^T7I&KPW&G6WAGQMH%P\NI>&HKQKU)-%GE T[5M/N)887N8%+"
MUN#L!BN$4D*EU"#&<9)6RN5)\RJ8:IM4M:\EO'3;Y;V?8VRK-J68PE#D]CB8
M:N&]H][_ -6/E/\ X*"? R\MH=1^,OARU,UA=VMC8>-K>%,M8W<30V=AX@*K
M]ZSFMUM[2X./W<D4$AW"X=H>CAZO&.88:$K>]-15TNJ:/FN*,FG[:GF%#X'9
M5(I7M;KK?3\/O/@+PKXZO;3X/>.HI8WFO;#Q%X"M+*XD*LACNK+QKY37&6W,
MT$=O(!V;";NAKZ',>'Z53.*";4:-:+G*"O:3@]=;W6ZV:V/SQ\.8;$K%UH3]
MG2JU</.K#6TI*4]-_=3?2'*EV/>?V(O@C?\ Q;\4#Q!K$+MX-\)>(AJ>N74X
M8C5]52"RO++0HS(?WCSRJLUW][9;'!VO=1,>'BNHJ-6A2I24?9045&,8Z):6
MV/K\CR66.Q%&4J7L\)@;)K5+W=H)_$T]'=MOS/HK_@I=\)=1U+3O"'QATFSD
MN(?#ML_A/Q6T:&5[/2[F\>]T#4) H/EV<6I7>IVTLAZ2:I9],MA\(YA&C5K9
M?4DOWWOPOI[]K>71+3UT/HN*,'4E&EBZ2LJ4>2223:CUTL_O/D_]D;]K>?\
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KJ V^0F,?A_2A+ET_X/YAY"X_S]*-OD%K?(,?I_2AKH&WE8.GX4;?(-C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g461805dsp01a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g461805dsp01a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M\C_X?_[BG_IDU&OI.#?^2DRW_N8_]1:YZ>6?[[0_[?\ _3<C[/K]U/JPH *
M"@!".,9Q[CM0M/D*2;BTGR^8F. ../Z?A3O83CHEO;^O,0KQ@<8_#'Z4KM>A
M2?+:RV^6WR9S7B3P;X;\76+:;XET32]:LF1U,.HV=O=;-X +0231,]O)\HQ)
M$R,IY!R!C*K0H5X\M6E&26UTG;\-+>1YN8Y1E>;4U1S' 4,53M)>_3A)QNDF
MXN4&[Z=&MNO3XN^(/[%.F7.^^^&^LKI$BK,[:'KK37EBS89DBL=32%[JT&<
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M_79%VD:1W0]>GXT&A>B^[^7\J:-UT)16<]UZ%QV/2OA-_P C_P"'_P#N*?\
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MV_KLB[2-([H>O3\:#0O1?=_+^5-&ZZ$HK.>Z]"X['I7PF_Y'_P /_P#<4_\
M3)J-?2<&_P#)29;_ -S'_J+7/3RS_?:'_;__ *;D?9]?NI]6% !0 4 % !0
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M *9-1KZ3@W_DI,M_[F/_ %%KGIY9_OM#_M__ --R/L^OW4^K"@ H * "@ H
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M=_+^5-&ZZ$HK.>Z]"X['I7PF_P"1_P##_P#W%/\ TR:C7TG!O_)29;_W,?\
MJ+7/3RS_ 'VA_P!O_P#IN1]GU^ZGU84 % !0 4 % !0 4 % !0 4 % !0 4
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MUFU>ROML?!<19(J4OK>$I+DUY[-*S<F[VDTW?R6A\S*,#D8.2.1@C!VD>Q#
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MQ3_TR:C7TG!O_)29;_W,?^HM<]/+/]]H?]O_ /IN1]GU^ZGU84 % !0 4 %
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M-OD=T'S6TL3CC_/I6<]UY(W2Y3TKX3?\C_X?_P"XI_Z9-1KZ3@W_ )*3+?\
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M /Z;D?9]?NI]6% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M^X__ *BUCU,L=\QP[VMSZ?\ <.9]HU^X'V 4 % !0 4 % !0 4 % !0 4 %
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MJ_<#[ * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@!".,=.GZ&CTT$U^%OP=_T/'OC+X<_MCPM)?Q9-WH!.H1*%W&2V!6.]
MA*@@E3$PEP#R;91WR/DN,LN6-RBO6C?GPD.9679IGEYOA?;X=SU_=K;TW/CL
M+@]<X_'I[U^+)<MNECY.W+IVT+")MP<_IC^M/] /2_A+_P E!\/_ /<5_P#3
M)J5?3<'_ /)19=_W'_\ 4:L>AE7^_P!#_M__ --S/M.OV\^Q"@ H * "@ H
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M .2BR[_N/_ZC5CORK_?Z'_;_ /Z;F?:=?MY]B% !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@!I Q^G/8=*+;>3NOEM^0)6=UHT?,OQNTA+;5M,UE6*I?VALY%_NS6,BL
MK9.>7MIG&/\ IW!ZDD_D_'N#Y,PH8R,;+$4Z=.3_ .GBG*-[/;W'!:66E[7N
MW\_F])1J4JJ5N9*+^3?^9R7PIX\?:#VQ_:GX8T74:\GA"T>(\#"WO0==7_[E
M*LO39G+EL;8^E;2,>;_TW(^R:_;CZH* "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * $(X]/TQB@#R;XQZ2;[PC+=J%\
MS1[F"_&=P;RB3:3@84_*$N YZ<1D]1@_'\:X7VV3SJJ*<\(_:)];0<9:>>CL
MM$>;FE+FPLJBM>C:3]$UMY_<>(?"G_D?M!]O[4Z\'C1=1[5\)P7*$<[P2J)N
MO5E7E%JUE%86I&S=TT[0>R:VU[>9EEEB*2>[<FO3V;_R/LFOVL^E"@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
MPO$>GC5=%U32R0HOM/N[9'Z[))8)%C?'0A9?+;!R#CD5Y^:X>.)RW'T6D[X>
MK9/OR2M^1E7A[3#XBGWIM)>?Z'RI\*P5\?Z$I&TJ=5! [$:-J((_.OR#A;]W
MQ7@*6RA]85O3"UV>#ER7UF']UR7_ )39]D5^WGT84 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % $;KN&,9&,8X&
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1 H * "@ H * "@ H * /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140362091168480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TEVA PHARMACEUTICAL INDUSTRIES LTD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  08,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">124 Dvora Hanevi&#8217;a Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6944020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3-914-8213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">American Depositary Shares, each representing one Ordinary Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TEVA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d461805d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="teva-20230608.xsd" xlink:type="simple"/>
    <context id="duration_2023-06-08_to_2023-06-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818686</identifier>
        </entity>
        <period>
            <startDate>2023-06-08</startDate>
            <endDate>2023-06-08</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-06-08_to_2023-06-08"
      id="Hidden_dei_EntityRegistrantName">TEVA PHARMACEUTICAL INDUSTRIES LTD</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-06-08_to_2023-06-08">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-06-08_to_2023-06-08"
      id="Hidden_dei_EntityCentralIndexKey">0000818686</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-06-08_to_2023-06-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-06-08_to_2023-06-08">2023-06-08</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-06-08_to_2023-06-08">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-06-08_to_2023-06-08">001-16174</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-06-08_to_2023-06-08">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-06-08_to_2023-06-08">124 Dvora Hanevi&#x2019;a Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-06-08_to_2023-06-08">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-06-08_to_2023-06-08">6944020</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="duration_2023-06-08_to_2023-06-08">IL</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="duration_2023-06-08_to_2023-06-08">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-06-08_to_2023-06-08">3-914-8213</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-06-08_to_2023-06-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-06-08_to_2023-06-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-06-08_to_2023-06-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-06-08_to_2023-06-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-06-08_to_2023-06-08">American Depositary Shares, each representing one Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-06-08_to_2023-06-08">TEVA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-06-08_to_2023-06-08">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-06-08_to_2023-06-08">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,92L88!.R
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M4$L! A0#%     @ W$/(5@=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #<0\A6ZQX92.X    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" #<0\A6F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( -Q#R%:.$5VC9P0  +@0   8
M      " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" #<0\A6GZ ;\+$"  #B#   #0              @ &J#   >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( -Q#R%:7BKL<P    !,"   +              "
M 88/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( -Q#R%8<.&7J/P$  #P"   /
M              "  6\0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #<
M0\A6)!Z;HJT   #X 0  &@              @ ';$0  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #<0\A699!YDAD!  #/ P  $P
M            @ ' $@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"   *%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d461805d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d461805d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d461805d8k.htm">d461805d8k.htm</File>
    <File>d461805dex991.htm</File>
    <File>teva-20230608.xsd</File>
    <File>teva-20230608_lab.xml</File>
    <File>teva-20230608_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d461805d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d461805d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "teva-20230608_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "teva-20230608_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "teva-20230608.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "teva",
   "nsuri": "http://www.tevapharm.com/20230608",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d461805d8k.htm",
      "contextRef": "duration_2023-06-08_to_2023-06-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d461805d8k.htm",
      "contextRef": "duration_2023-06-08_to_2023-06-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.tevapharm.com//20230608/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-23-163060-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-163060-xbrl.zip
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M!X0_CG:9-(GH@!5[DM%;+,%"?M^@8P$*LC+CJD9T^7E)1IE(3IL:1H_(S%I
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MQ_.?W,/];*;,-NL.:0XYZY-I-<R^YU.N&G&?E.VOOYK?ACW]/U!+ P04
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M   1              "  9,@  !T979A+3(P,C,P-C X+GAS9%!+ 0(4 Q0
M   ( -U#R%8D5@0L4P8  'E#   5              "  0 D  !T979A+3(P
M,C,P-C X7VQA8BYX;6Q02P$"% ,4    " #=0\A6XW/9K*\$  !E*@  %0
M            @ &&*@  =&5V82TR,#(S,#8P.%]P<F4N>&UL4$L%!@     %
-  4 0 $  &@O      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
